PubMed Health⌕ Search

Biomedical subjects

H T Epstein

Publications and source records attributed to H T Epstein.

At least 19 recordsLinked to original sources

Bryostatin enhancement of memory in Hermissenda.

Bryostatin, a potent agonist of protein kinase C (PKC), when administered to Hermissenda was found to affect acquisition of an associative learning paradigm. Low bryostatin concentrations (0.1 to 0.5 ng/ml) enhanced memory acquisition, while concentrations higher than 1.0 ng/ml down-regulated the pathway and no recall of the associative training was exhibited. The extent of enhancement depended upon the conditioning regime used and the memory stage normally fostered by that regime. The effects of two training events (TEs) with paired conditioned and unconditioned stimuli, which standardly evoked only short-term memory (STM) lasting 7 min, were--when bryostatin was added concurrently--enhanced to a long-term memory (LTM) that lasted about 20 h. The effects of both 4- and 6-paired TEs (which by themselves did not generate LTM), were also enhanced by bryostatin to induce a consolidated memory (CM) that lasted at least 5 days. The standard positive 9-TE regime typically produced a CM lasting at least 6 days. Low concentrations of bryostatin (<0.5 ng/ml) elicited no demonstrable enhancement of CM from 9-TEs. However, animals exposed to bryostatin concentrations higher than 1.0 ng/ml exhibited no behavioral learning. Sharp-electrode intracellular recordings of type-B photoreceptors in the eyes from animals conditioned in vivo with bryostatin revealed changes in input resistance and an enhanced long-lasting depolarization (LLD) in response to light. Likewise, quantitative immunocytochemical measurements using an antibody specific for the PKC-activated Ca2+/GTP-binding protein calexcitin showed enhanced antibody labeling with bryostatin. Animals exposed to the PKC inhibitor bisindolylmaleimide-XI (Ro-32-0432) administered by immersion prior to 9-TE conditioning showed no training-induced changes with or without bryostatin exposure. However, if animals received bryostatin before Ro-32, the enhanced acquisition and demonstrated recall still occurred. Therefore, pathways responsible for the enhancement effects induced by bryostatin were putatively mediated by PKC. Overall, the data indicated that PKC activation occurred and calexcitin levels were raised during the acquisition phases of associative conditioning and memory initiation, and subsequently returned to baseline levels within 24 and 48 h, respectively. Therefore, the protracted recall measured by the testing regime used was probably due to bryostatin-induced changes during the acquisition and facilitated storage of memory, and not necessarily to enhanced recall of the stored memory when tested many days after training.

Animals↗

An outline of the role of brain in human cognitive development.

Brain development in humans occurs stagewise in correlation with the onsets of the main Piagetian stages of reasoning development. This allows a description of cognitive development as at least partially resulting from and dependent upon biological events occurring in the brain. Evidence shows that some eventual brain structures depend on a combination of biological events and instructional inputs. This contributes to the instruction dependence of the higher cognitive functions. Such a description thereby permits some novel working hypotheses about normal cognitive development and how to foster it as well as suggests alternative ways of creating intervention programs for children from deprived environments.

Adolescent↗

Pavlovian conditioning-specific increases of the Ca2+- and GTP-binding protein, calexcitin in identified Hermissenda visual cells.

Hermissenda CNS, immunolabeled for the memory protein calexcitin showed significant immunostaining over background in the B-photoreceptor cells of the eye. The degree of staining correlated positively with the number of Pavlovian training events experienced by the animals and the degree of Pavlovian conditioning induced. The training regime consisted of exposing animals to light (conditioned stimulus, CS) paired with orbital rotation (unconditioned stimulus, US). In animals that exhibited the conditioned response, calexcitin immunolabeling was more intense than was found for naive (unconditioned) animals or animals given the CS and US in random sequence. Animals exposed to lead (maintained in 1.2 ppm lead acetate) at a dosage known to impair learning in children, showed reduced learning and less intense calexcitin staining whether the CS and US were paired or given randomly. However, the levels were still higher than that of naive animals. Immuno-electron microscopy indicated that the labeling was predominantly within calcium sequestering organelles such as the endoplasmic reticulum, and to lesser extent within mitochondria, and photopigments. The calexcitin density after a short-term memory (STM) regime was the same whether measured 5 minutes after conditioning (when STM was evidenced by foot contraction) or 90 minutes later when no recall was detected. The staining density was also similar to the levels found 5 minutes after long-term memory (LTM) conditioning. However, the LTM regime produced a greater calexcitin intensity at 90 minutes when the memory had been consolidated. This learning-specific increase in calexcitin is consistent with the previously implicated sequence of molecular events that are associated with progressively longer time domains of memory storage.

Animals↗

Stages of increased cerebral blood flow accompany stages of rapid brain growth.

Stages of increased cerebral blood flow accompany stages of rapid brain growth The existence of stages of rapid brain growth implies the existence of associated stages of increased cerebral blood flow (CBF) to supply the substances and energy needed for the added brain weight. Studies in the literature give developmental data for CBF in humans which show stages of increased cerebral blood flow at ages starting just preceding and/or coincident with the ages of the rapid brain growth stages. Confirmation of the implication for one of the earliest stages is also found in PET data. Additionally, data for rodents show a similar association of stages of increasing CBF and their brain growth stages. Thus, to the accuracy of the data, the implication is confirmed. Finding stages in cerebral blood flow predicts the existence of stages of brain growth. In addition; finding correlated blood flow stages also supports the age spans of the stages of rapid brain growth in both species. Such correlations also suggest that measurements of blood flow anywhere in the body might serve to reveal rapid growth stages in particular localities or organs if the blood flow shows significant stages. The ratio of energy consumed in brain to that in total body decreases from close to 100% at birth to the adult value of about 20% by age 18 years.

Adolescent↗

Lead effects on offspring depend on when mouse mothers were exposed to lead.

Target mice were nursed by mothers given lead starting (1) when target mice were born; (2) after conception of target mice, or (3) during the mothers' own pre-weaning age. These target mice are called, respectively, POSTNATAL, GESTATIONAL, and PRE-MATING. Compared to developments in control mice, postnatal lead slowed brain weight development, lowered asymptotic brain weight, decreased DNA per brain somewhat, but had no effect on protein per brain. Gestational lead similarly slowed brain weight development, lowered asymptotic brain weight, greatly decreased DNA per brain, but had no effect on protein per brain. In contrast, pre-mating lead significantly increased brain weight and protein per brain and lowered DNA per brain substantially. These effects of pre-mating lead on brain weight and protein per brain could be due to the effects of lead on developing maternal reproductive systems or to lead's presence during the rarely studied ovulation-to-fertilization period.

Animals↗

Lead acetate delays rapid postnatal mouse brain and body growth.

Starting at parturition and continuing until weaning, mothers of five mouse litters received tap water while five others had 10 mg PbAc/ml in their drinking water. The offspring receiving lead from the mothers had significantly lower body weights after the first days of receiving lead; their slowed body growth led to a 2-day delay of onset (usually at 16-18 days) of their last rapid body growth stage. They also had significantly smaller brain weights between age 14 days and weaning (23 days). The onset of rapid brain growth was delayed from its usual onset at 16-18 days to about 22-23 days before rising to about the same value as the control mice at 26 days. Thus, the initial effect on brain growth is decidedly greater than on body growth, though brain weight later reaches close to the control value.

Animals↗

Strain differences in mouse brain weight gain and spatial-location scores during postnatal development.

Brain weight and performance on a spatial-location test were measured from birth to weaning on mouse strains CD1, Balb/c, and their F1 cross. For CD1, onsets of both the last rapid-brain-growth stage and nonzero scores on the spatial-location test were around age 17 days; asymptotes of both were reached about age 23 days. Balb/c and F1 had at least 5- to 6-day delays of both onsets and asymptotes. For the strains studied, onset of nonzero performance on the spatial-location test may be a provisional indicator of onset of significant and rapid brain growth after age 15 days. The delayed F1 brain growth stage could indicate that control of brain growth about age 20 days resides in an inhibitory factor present in Balb/c but not in CD1.

Animals↗

Stages in human brain development.

In a 1974 survey of data on human brain and head growth statistically significant peaks in growth rates of human brains were found around ages 11 years and 15 years. In addition, correlations were found in that almost all studies had non-significant peaks around ages 3, 7, 11-12 and 15 years; troughs were found at the intermediate ages (5, 9, and 13 years). More recent data include a very extensive collection of head circumference data from a dozen countries which showed statistically significant peaks around ages 7, 12, and 15 years. Confirmation of those results have been found in data on cortical thickness, photographs of neuronal arbors, and the percent of EEG energy found in the alpha-frequencies (8-13 cps). The proposed peak around age 3 years cannot be decided from existing brain weight and head circumference data bases, but the EEG data and the cortical thickness data supply significant support. Overall, there are statistically significant peaks in brain growth rates at age 7, 11-12, and 15 years, though the latter holds only for males at present. The significance of the stages for development of brain functions is being explored.

Adolescent↗

EEG developmental stages.

Data in the literature show that in humans the fraction of the total electroencephalographic (EEG) energy that appears in the alpha frequencies rises from about zero at birth to about 70% in adults. This rise is shown to occur mainly in 5 stages, the ages of which correlate with those of stages of increase in brain weight. Supporting the correlation are data on gender dimorphism in humans in both brain weight and EEG development, as well as limited data on development in kittens, rats, mice, and guinea pigs.

Adolescent↗

Three parameters affecting interlitter variations.

We studied 3 parameters affecting average body weight differences between mouse litters and have arrived at an approximation of the contribution that each makes to such differences. These parameters are birth weight, genetically based growth potential variations, and maternal competence. We have developed methods for controlling these parameters and show that through their application we can reduce litter-average body weight differences from our normal value of more than 24% to about 3%. The vanished 21% consists of 12% due to differences in maternal competence, 6% due to growth potential differences, and 3% due to initial weight differences.

Age Factors↗

The relationship between brain weight and head circumference from birth to age 18 years.

A relation between head circumference and brain weight of humans is generally believed to exist, but the literature contains only two studies which exhibit a quantitative aspect of the relation, showing that brain weight is proportional to the cube of the head circumference from birth through age 3.5 years. By assembling data from autopsy records, we have been able to show that this cubic relationship holds through brain maturation at around age 18 years.

Adolescent↗

The effect of litter size on weight gain in mice.

The body weights of rodents at weaning are generally believed to be inversely related to the number of animals in the litter during the birth-to-weaning period. Quantitative data for rats have been published, but not for mice. Using carefully matched litters, we have measured the average body weights of mice raised in litters containing 2, 4, 6, and 12 pups relative to the average body weight of litters of eight pups. Except for the 2 pup litters, the inverse relation was found to hold. It is also shown that the pattern of average weaning weight as a function of litter size is the same as previously published by two other groups using rats.

Aging↗